Galvus and Galvus Met, new registered medicinal agents for the treatment of diabetes mellitus
Guardado en:
Autor principal: | Editorial team Diabetes Mellitus |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e2770f1dacd84078a585bca7f794c4ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010) -
Vildagliptin and its role in the treatment of diabetes mellitus
por: Yury Shavkatovich Khalimov
Publicado: (2010) -
Resolution on Diabetes Mellitus from United Nations organization
por: Editorial team Diabetes Mellitus
Publicado: (2007) -
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
por: Editorial team Diabetes Mellitus
Publicado: (2012) -
The new drug saxagliptin is now registrated in Russia
por: Editorial team Diabetes Mellitus
Publicado: (2010)